21270-Peritoneal Cancer-NA-412

Peritoneal Cancer

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ZN-c3-005| GOG 3066)

  • Details

ClinicalTrials.gov ID: NCT05128825
Diagnosis Type: NA
USOR Number:

  • Address


,
P:

Search by practice name, trial titles, indicators and specific disease types.